QLS-111 Ophthalmic Solution

· Qlaris Bio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QLS-111 Ophthalmic Solution, covering 2026-02-24 to 2026-02-24. Get the full timeline:

Most recent: Clinical Trial Update: Single-site Pilot Study Evaluating the Effect of QLS-111 Ophthalmic Solution on Posterior Perfusion and Vessel Dilation [Phase 2]

See pricing